Regulation of Syk kinase and FcRβ expression in human basophils during treatment with omalizumab
- 18 March 2010
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 125 (4) , 902-908.e7
- https://doi.org/10.1016/j.jaci.2009.12.996
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challengeJournal of Allergy and Clinical Immunology, 2009
- Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophilsJournal of Leukocyte Biology, 2009
- Reduced FcεRI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab TherapyInternational Archives of Allergy and Immunology, 2009
- Hyperexpression of the High-Affinity IgE Receptor-β Chain in Chronic Allergic KeratoconjunctivitisInvestigative Opthalmology & Visual Science, 2009
- The Effect of Omalizumab on Basophil and Mast Cell Responses using an Intranasal Cat Allergen ChallengeJournal of Allergy and Clinical Immunology, 2009
- Basophil Phenotypes in Chronic Idiopathic Urticaria in Relation to Disease Activity and AutoantibodiesJournal of Investigative Dermatology, 2008
- Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticariaPublished by Elsevier ,2005
- Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆Journal of Allergy and Clinical Immunology, 2004
- Omalizumab treatment downregulates dendritic cell FcεRI expressionJournal of Allergy and Clinical Immunology, 2003
- Expression and modulation of FcϵRIα and FcϵRIβ in human blood basophilsJournal of Allergy and Clinical Immunology, 2001